However, among patients whose cardiac arrest was witnessed by a bystander, those who received either amiodarone or lidocaine during resuscitation had a 5 percent greater chance of survival to ...

Multi-microsecond simulations of lidocaine (antiarrhythmic and local anesthetic drug) interacting with sodium channels revealed a channel pore access pathway through the intracellular gate and a ...

Lidocaine is a class IB antiarrhythmic drug used for the treatment of ventricular arrhythmias, specifically ventricular tachycardia and ventricular fibrillation.

Certain antiarrhythmic drugs improve the chances of patient survival when administered by paramedics to patients with out-of-hospital cardiac arrest who had failed electric shock treatment, a ...

Europe represents a mature market, with significant growth observed in Germany, France, and the UK. Strong adoption of lidocaine in both clinical anesthesiology and aesthetic dermatology contributes ...

Multi-microsecond simulations of lidocaine (antiarrhythmic and local anesthetic drug) interacting with sodium channels revealed a channel pore access pathway through the intracellular gate and a ...

In Brief Published: 21 April 2016 Cardiac resuscitation Antiarrhythmic drugs in out-of-hospital cardiac arrest Gregory B. Lim Nature Reviews Cardiology 13, 313 (2016) Cite this article ...

Bramah N. Singh, MD, D PhilMADIT II Another trial that has excited a great deal of controversy is the second MADIT II. The first MADIT was a relatively small trial (196 patients) that identified ...

"Mixed results on benefits of antiarrhythmic drugs for out-of-hospital cardiac arrest." ScienceDaily. ScienceDaily, 4 April 2016. <www.sciencedaily.com / releases / 2016 / 04 / 160404181008.htm>.

This trial is the first and largest randomized, double-blind, placebo-controlled study to assess the impact of amiodarone and lidocaine on survival to hospital discharge after out-of-hospital ...

Amiodarone more effective than lidocaine in ACLS for shock-resistant ventricular fibrillation Fran Lowry May 07, 2001 0 Mon, 07 May 2001 17:00:00 ...

Among the three treatment groups, 24.4 percent of patients given amiodarone, 23.7 percent of patients treated with lidocaine and 21 percent of patients receiving a placebo survived their heart attack.